Publications by authors named "Daniel Enriquez-Vera"

Background: Breast cancer is an important cause of cancer-related death in women worldwide and represents the second most frequent cause of brain metastases after lung cancer. The aim of this study was to determine the characteristics and outcomes of triple-negative breast cancer (TNBC) patients with brain metastasis (BM).

Methods: We retrospectively reviewed a cohort of patients diagnosed with TNBC at the "Instituto Nacional de Enfermedades Neoplasicas" (period 2000-2014) to evaluate patients who developed BM.

View Article and Find Full Text PDF

Adult T-cell leukemia/lymphoma (ATLL) is a refractory blood cancer with severe immunodeficiency resulting from retroviral infection. ATLL develops in only 5 % of HTLV-1-infected individuals, but the entire mechanism of ATLL progression remains unknown. Since recent studies have reported that the gut microbiome influences the progression of various diseases, we hypothesized that ATLL is also related to the gut microbiome and aimed to investigate this relationship.

View Article and Find Full Text PDF

Epstein-Barr virus (EBV) is a potent carcinogen linked to hematologic and solid malignancies and causes significant global morbidity and mortality. Therapy using allogeneic EBV-specific lymphocytes shows promise in certain populations, but the impact of EBV genome variation on these strategies remains unexplored. To address this, we sequenced 217 EBV genomes, including hematologic malignancies from Guatemala, Peru, Malawi, and Taiwan, and analyzed them alongside 1307 publicly available EBV genomes from cancer, nonmalignant diseases, and healthy individuals across Africa, Asia, Europe, North America, and South America.

View Article and Find Full Text PDF

The recommended first-line chemotherapy agents for managing Kaposi sarcoma (KS) in high-income countries are expensive and often unavailable in developing nations such as Peru. Limited data exist on whether management practices in these countries affect patient outcomes. We assessed the real-world treatment approaches and outcomes of patients with KS in Peru.

View Article and Find Full Text PDF

Human T-cell leukemia virus type-1 (HTLV-1) causes adult T-cell leukemia/lymphoma (ATL). HTLV-1 carriers have a lifelong asymptomatic balance between infected cells and host antiviral immunity; however, 5-10% of carriers lose this balance and develop ATL. Coinfection with promotes ATL development, suggesting that the immunological status of infected individuals is a determinant of HTLV-1 pathogenicity.

View Article and Find Full Text PDF
Article Synopsis
  • * A study of 90 AYAs in Peru showed a 91% overall response rate to R-CHOP, with 5-year overall survival (OS) and progression-free survival (PFS) rates of 79% and 67%, respectively.
  • * Despite comparable outcomes to adults, those with relapsed/refractory disease had poor prognosis, highlighting the need for better and more accessible treatment options for AYAs with DLBCL.
View Article and Find Full Text PDF
Article Synopsis
  • HTLV-1, an endemic virus in Latin America, is linked to worse outcomes in cancer patients, particularly those with adult T-cell leukemia/lymphoma (ATL) and non-ATL cancers.
  • A study analyzed 1,934 HTLV-1 carriers diagnosed with various cancers, finding that non-ATL malignancies, especially cervical cancer in females and non-Hodgkin lymphoma in males, had lower overall survival rates compared to the general population.
  • The research highlights the vulnerability of certain demographics, such as middle-aged individuals from underprivileged backgrounds, and calls for further investigation into HTLV-1's impact on cancer outcomes and the need for screening in affected regions.
View Article and Find Full Text PDF

Outcomes of females with triple-negative breast cancer (TNBC) are rarely explored in adolescents and young adults (AYAs). We compared clinical and survival outcomes of Latin American AYAs (≤39 years) with middle-aged (40-59 years) and older (≥60 years) females with TNBC by cancer stage. We performed a single-center retrospective cohort study among treated females with cancer stages I-III diagnosed from 2000 to 2014 in Peru.

View Article and Find Full Text PDF

Background: Breast cancer incidence in the United States is lower in Hispanic/Latina (H/L) compared with African American/Black or Non-Hispanic White women. An Indigenous American breast cancer-protective germline variant (rs140068132) has been reported near the estrogen receptor 1 gene. This study tests the association of rs140068132 and other polymorphisms in the 6q25 region with subtype-specific breast cancer risk in H/Ls of high Indigenous American ancestry.

View Article and Find Full Text PDF

Introduction: Anemia is a global public health issue that affects mainly children aged less than 5 years. In Peru, despite the reduction in the prevalence of anemia between 2010 and 2018, anemia remains a major concern, especially in high-risk zones such as rural areas. Several sociodemographic factors have been associated with anemia in children; however, components contributing to the urban-rural gap have not been previously assessed.

View Article and Find Full Text PDF

Unlabelled: Extranodal natural killer/T-cell lymphoma (ENKTL) is an aggressive, rare lymphoma of natural killer (NK) cell origin with poor clinical outcomes. Here we used phenotypic and molecular profiling, including epigenetic analyses, to investigate how ENKTL ontogeny relates to normal NK-cell development. We demonstrate that neoplastic NK cells are stably, but reversibly, arrested at earlier stages of NK-cell maturation.

View Article and Find Full Text PDF

Venetoclax combinations are a new standard for patients with acute myeloid leukemia (AML). We aimed to evaluate the safety and efficacy of these combinations in a period of accelerated approval in Latin-America. This observational study evaluated adults with acute myeloid leukemia who received venetoclax-based therapy in 11 public or private centers in Mexico and Peru for both newly diagnosed or relapsed and refractory AML.

View Article and Find Full Text PDF
Article Synopsis
  • * Researchers analyzed the medical records of 37 patients over 17 years, finding that those with community-acquired bacteremia had significantly lower overall survival rates within 30 days compared to those with healthcare-associated bacteremia.
  • * Key symptoms included abdominal pain, and the study suggested that community-acquired bacteremia presents a worse disease severity, which should help clinicians in prognosis determination for these patients.
View Article and Find Full Text PDF